| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 19 |
| 1 | METHOTREXATE SODIUM | 16 |
| 2 | METHOTREXATE | 14 |
| 3 | ADALIMUMAB-ADAZ | 10 |
| 4 | ISOTRETINOIN | 10 |
| 5 | PREDNISOLONE | 10 |
| 6 | PREDNISOLONE ORAL | 10 |
| 7 | PREDNISOLONE ORAL SOLUTION | 10 |
| 8 | ADALIMUMAB-AATY | 8 |
| 9 | ADALIMUMAB-FKJP | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 12%AZELAIC ACID | 4 | 0.0048 |
| 1 | AZELAIC ACID | 4 | 0.0040 |
| 2 | TAGRAXOFUSP | 2 | 0.0037 |
| 3 | PEXIDARTINIB HYDROCHLORIDE | 1 | 0.0014 |
| 4 | RYDAPT | 2 | 0.0010 |
| 5 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 1 | 0.0009 |
| 6 | RASBURICASE | 2 | 0.0008 |
| 7 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 8 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 9 | INSULIN ASPART INJECTION | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 16 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 4 | Retinoid [EPC] | 11 |
| 5 | Alkylating Drug [EPC] | 8 |
| 6 | Kinase Inhibitor [EPC] | 8 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 6 |
| 8 | Aromatase Inhibitor [EPC] | 5 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD123 Interaction [EPC] | 2 | 0.0037 |
| 1 | Interferon gamma [EPC] | 1 | 0.0007 |
| 2 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 3 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 4 | TRPM8 Thermoreceptor Agonist [EPC] | 1 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 4 | 0.0001 |
| 7 | Typical Antipsychotic [EPC] | 2 | 0.0001 |
| 8 | PCSK9 Inhibitor [EPC] | 2 | 0.0001 |
| 9 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |